Incidence, impact, and predictors of cranial nerve palsy and haematoma following carotid endarterectomy in the international carotid stenting study.

D Doig, E L Turner, J Dobson, R L Featherstone, G J de Borst, M M Brown, T Richards

Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2015;48(5):498-504

PMID: 25344019

Abstract

OBJECTIVE

Cranial nerve palsy (CNP) and neck haematoma are complications of carotid endarterectomy (CEA). The effects of patient factors and surgical technique were analysed on the risk, and impact on disability, of CNP or haematoma in the surgical arm of the International Carotid Stenting Study (ICSS), a randomized controlled clinical trial of stenting versus CEA in patients with symptomatic carotid stenosis.

MATERIALS AND METHODS

A per-protocol analysis of early outcome in patients receiving CEA in ICSS is reported. Haematoma was defined by the surgeon. CNP was confirmed by an independent neurologist. Factors associated with the risk of CNP and haematoma were investigated in a binomial regression analysis.

RESULTS

Of the patients undergoing CEA, 45/821 (5.5%) developed CNP, one of which was disabling (modified Rankin score = 3 at 1 month). Twenty-eight (3.4%) developed severe haematoma. Twelve patients with haematoma also had CNP, a significant association (p < .01). Independent risk factors modifying the risk of CNP were cardiac failure (risk ratio [RR] 2.66, 95% CI 1.11 to 6.40), female sex (RR 1.80, 95% CI 1.02 to 3.20), the degree of contralateral carotid stenosis, and time from randomization to treatment >14 days (RR 3.33, 95% CI 1.05 to 10.57). The risk of haematoma was increased in women, by the prescription of anticoagulant drugs pre-procedure and in patients with atrial fibrillation, and was decreased in patients in whom a shunt was used and in those with a higher baseline cholesterol level.

CONCLUSIONS

CNP remains relatively common after CEA, but is rarely disabling. Women should be warned about an increased risk. Attention to haemostasis might reduce the incidence of CNP. ICSS is a registered clinical trial: ISRCTN 25337470.

Copyright © 2014. Published by Elsevier Ltd.

Address: Institute of Neurology, University College London, London, UK.; Department of Biostatistics and Bioinformatics and Duke Global Health Institute, Duke University, Durham, NC, USA.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.; Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.; Institute of Neurology, University College London, London, UK. Electronic address: [email protected].; Department of Surgical and Interventional Sciences, University College London, London, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.